Pharsight

1. Drug name - AURYXIA

Patent Number	Company	Patent Title	Patent Expiry
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US9328133	KERYX BIOPHARMS	Ferric organic compounds, uses thereof and methods of making same	Feb, 2024 (1 year, 4 months from now)
US9757416	KERYX BIOPHARMS	Pharmaceutical-grade ferric organic compounds, uses thereof and methods of making same	Feb, 2024 (1 year, 4 months from now)
US8338642	KERYX BIOPHARMS	Ferric organic compounds, uses thereof and methods of making same	Feb, 2024 (1 year, 4 months from now)
US7767851	KERYX BIOPHARMS	Ferric organic compounds, uses thereof and methods of making same	Feb, 2024 (1 year, 4 months from now)
CN101253186A	KERYX BIOPHARMS	Pharmaceutical-Grade Ferric Organic Compound, Uses Thereof And Methods Of Making Same	Feb, 2013 (9 years ago)
CN101374416A	KERYX BIOPHARMS	Method Of Reversing, Preventing, Delaying Or Stabilizing Soft Tissue Calcification	Mar, 2016 (6 years ago)
CN101378658A	KERYX BIOPHARMS	Method Of Treating Chronic Kidney Disease	Dec, 2016 (5 years ago)
CN101014618A	KERYX BIOPHARMS	Antigenic Oligomeric Assembling Polypeptide	Sep, 2017 (5 years ago)
CN101014618B	KERYX BIOPHARMS	Polypeptides For Oligomeric Assembly Of Antigens	Sep, 2017 (5 years ago)
CN100386336C	KERYX BIOPHARMS	Ferric Organic Compound, Its Preparation Method And Its Application	Feb, 2024 (1 year, 4 months from now)
CN1751056A	KERYX BIOPHARMS	Ferric Organic Compound, Its Preparation Method And Its Application	Feb, 2024 (1 year, 4 months from now)
CN105055446A	KERYX BIOPHARMS	Method Of Reversing, Preventing, Delaying Or Stabilizing Soft Tissue Calcification	Aug, 2026 (3 years from now)
CN105055446B	KERYX BIOPHARMS	Method For Reversing, Preventing, Delaying Or Stabilizing Soft Tissue Calcification	Aug, 2026 (3 years from now)
IN244119B	KERYX BIOPHARMS	Ferric Organic Compounds, Uses Thereof And Methods Of Making Same	Feb, 2024 (1 year, 4 months from now)
IN200500944P3	KERYX BIOPHARMS	Ferric Organic Compounds, Uses Thereof And Methods Of Making Same	Feb, 2024 (1 year, 4 months from now)
EP1601680B8	KERYX BIOPHARMS	Methods Of Making Ferric Organic Compounds	Feb, 2024 (1 year, 4 months from now)
EP1601680B1	KERYX BIOPHARMS	Methods Of Making Ferric Organic Compounds	Feb, 2024 (1 year, 4 months from now)
EP1601680A4	KERYX BIOPHARMS	Ferric Organic Compounds, Uses Thereof And Methods Of Making Same	Feb, 2024 (1 year, 4 months from now)
EP1601680A2	KERYX BIOPHARMS	Methods Of Making Ferric Organic Compounds	Feb, 2024 (1 year, 4 months from now)
EP1778725B1	KERYX BIOPHARMS	Polypeptides For Oligomeric Assembly Of Antigens	Jul, 2025 (2 years from now)
EP1778725A2	KERYX BIOPHARMS	Polypeptides For Oligomeric Assembly Of Antigens	Jul, 2025 (2 years from now)
EP1931689A4	KERYX BIOPHARMS	Pharmaceutical-Grade Ferric Organic Compounds, Uses Thereof And Methods Of Making Same	Aug, 2026 (3 years from now)
EP1931689A2	KERYX BIOPHARMS	Pharmaceutical-Grade Ferric Citrate For Medical Use	Aug, 2026 (3 years from now)
EP1931689B1	KERYX BIOPHARMS	Pharmaceutical-Grade Ferric Citrate For Medical Use	Aug, 2026 (3 years from now)
EP1978808B1	KERYX BIOPHARMS	Ferric Citrate For Reversing, Preventing, Delaying Or Stabilizing Soft Tissue Calcification	Jan, 2027 (4 years from now)
EP1978808A2	KERYX BIOPHARMS	Ferric Citrate For Reversing, Preventing, Delaying Or Stabilizing Soft Tissue Calcification	Jan, 2027 (4 years from now)
EP1978807A4	KERYX BIOPHARMS	Method Of Treating Chronic Kidney Disease	Jan, 2027 (4 years from now)
EP1978807B1	KERYX BIOPHARMS	Method Of Treating Chronic Kidney Disease	Jan, 2027 (4 years from now)
EP1978807A2	KERYX BIOPHARMS	Method Of Treating Chronic Kidney Disease	Jan, 2027 (4 years from now)
EP1978808A4	KERYX BIOPHARMS	Method Of Reversing, Preventing, Delaying Or Stabilizing Soft Tissue Calcification	Jan, 2027 (4 years from now)
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9050316	KERYX BIOPHARMS	Pharmaceutical-grade ferric organic compounds, uses thereof and methods of making same	Feb, 2024 (1 year, 4 months from now)
US8846976	KERYX BIOPHARMS	Ferric organic compounds, uses thereof and methods of making same	Feb, 2024 (1 year, 4 months from now)
US8299298	KERYX BIOPHARMS	Pharmaceutical-grade ferric organic compounds, uses thereof and method of making same	Feb, 2024 (1 year, 4 months from now)
US8754257	KERYX BIOPHARMS	Pharmaceutical-grade ferric organic compounds, uses thereof and methods of making same	Feb, 2024 (1 year, 4 months from now)
US8609896	KERYX BIOPHARMS	Ferric organic compounds, uses thereof and methods of making same	Feb, 2024 (1 year, 4 months from now)
US8901349	KERYX BIOPHARMS	Ferric organic compounds, uses thereof and methods of making same	Feb, 2024 (1 year, 4 months from now)
US8754258	KERYX BIOPHARMS	Ferric organic compounds, uses thereof and methods of making same	Feb, 2024 (1 year, 4 months from now)
US8093423	KERYX BIOPHARMS	Pharmaceutical-grade ferric organic compounds, uses thereof and method of making same	Apr, 2026 (3 years from now)
US10300039	KERYX BIOPHARMS	Ferric citrate dosage forms	Jul, 2030 (7 years from now)
US9387191	KERYX BIOPHARMS	Ferric citrate dosage forms	Jul, 2030 (7 years from now)

Drugs and Companies using FERRIC CITRATE ingredient

Treatment: Control of serum phosphorous levels; Control of serum phosphorus levels

Dosage: TABLET;ORAL

Strength	Dosage	Availability
EQ 210MG IRON	TABLET;ORAL	Prescription

Pharsight

Drug Patents owned by Keryx Biopharms

1. Drug name - AURYXIA

availability in other generic markets.

Click on the highlighted region to filter.

Pharsight

Drug Patents owned by Keryx Biopharms

1. Drug name - AURYXIA

availability in other generic markets. Click on the highlighted region to filter.

availability in other generic markets.

Click on the highlighted region to filter.